Aflac Surpasses $200 Million in Contributions for Childhood Cancer and Blood Disorders
Aflac is marking National Childhood Cancer and Sickle Cell Disease Awareness Month by announcing it has surpassed $200 million in contributions to treatment and research over more than 30 years. The company, employees, and independent sales agents have backed the Aflac Cancer and Blood Disorders Center in Atlanta since 1995, and the Aflac Childhood Cancer Foundation awarded 12 Child Life program grants nationwide.